Dr. Harish Kancharla

About Dr. Harish Kancharla

Dr. Harish Kancharla is a Senior Consultant Medical Oncologist and Hemato-Oncologist based in Hyderabad, India, with over 9 years of focused experience in chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation. He is widely regarded among patients searching for the best Medical Oncologist in Hyderabad for his AIIMS-trained expertise and evidence-based, patient-first approach to cancer care.

9+ years of clinical experience in medical and hemato-oncology
DM in Medical Oncology from AIIMS, New Delhi (BRAIRCH)
All India 1st Rank in DM/MCh Entrance for Medical Oncology, 2017
15+ peer-reviewed publications in international oncology journals
Multiple national quiz and best abstract awards in oncology

Qualifications & Credentials

Medical Degrees

MBBS — Gandhi Medical College, Hyderabad (Dr. NTR University of Health Sciences, Andhra Pradesh), 2012
MD (Internal Medicine) — Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, 2015
DM (Medical Oncology) — All India Institute of Medical Sciences (AIIMS), New Delhi (BRAIRCH), 2020

Fellowships & Special Training

Senior Residency in Medical Oncology — BRAIRCH, AIIMS, New Delhi, 2016–2020
Senior Residency in Internal Medicine — PGIMER, Chandigarh, 2016

Certifications & Accreditations

Telangana State Medical Council Registration
Member — International Association for the Study of Lung Cancer (IASLC)
Member — European Society for Medical Oncology (ESMO)
Member — Indian Cooperative Oncology Network (ICON)

Areas of Expertise

Major Conditions Treated

Lung Cancer (Small Cell & Non-Small Cell)
Breast Cancer
Gastrointestinal Cancers (Stomach, Colon, Rectum)
Liver and Pancreatic Cancers
Genitourinary Cancers (Prostate, Kidney, Bladder)
Head and Neck Cancers
Hematological Malignancies (Leukaemia, Lymphoma, Myeloma)
Multiple Myeloma
Bone Marrow Failure Syndromes
Sarcomas

Sub-specialties

Hemato-Oncology & Bone Marrow Transplantation: Comprehensive care for leukaemia, lymphoma, and multiple myeloma — a trusted Medical Oncologist in Hyderabad for patients seeking the best blood cancer doctor in India.
Precision Oncology & Targeted Therapy: Use of molecular profiling and targeted agents (EGFR, ALK, HER2) for personalised cancer care.
Immuno-Oncology: Checkpoint inhibitors (PD-1, PD-L1) for advanced solid tumours and lymphomas.

Advanced Procedures & Treatments

Chemotherapy (Solid Tumours and Hematolymphoid Malignancies)
Targeted Therapy (Precision Oncology)
Immunotherapy / Checkpoint Inhibitors
Hormonal Therapy (Breast and Prostate Cancer)
Bone Marrow / Stem Cell Transplantation
Tumour Marker Monitoring and Molecular Profiling

List of Disease and Treatment for which Dr. Harish Kancharla can be consulted

Professional Experience

Current Affiliation

Yashoda Hospitals, Somajiguda, Hyderabad — Consultant Medical Oncologist & Hemato-Oncologist (Present)
Aster Prime Hospital, Hyderabad — Consultant Medical Oncologist (Present)

Past Affiliations

Cancer Clinics, Hyderabad — Consultant Medical Oncology and Hemato-Oncology, July 2020 – May 2021
BRAIRCH, AIIMS, New Delhi — Senior Resident in Medical Oncology, 2016–2020
PGIMER, Chandigarh — Senior Resident in Internal Medicine, January 2016 – September 2016

Academic & Research Roles

Author of 15+ peer-reviewed publications in international oncology journals
Presenter at WCLC 2019 (Barcelona, Spain) and APLAR 2017 (Dubai)

Key Achievements

All India 1st Rank in DM/MCh Entrance, Medical Oncology, April 2017
First Prize — Hematology Update National Quiz, Delhi, 2019
First Prize — Update in Management of Breast Cancer National Quiz, AIIMS Delhi, 2017
Best Abstract (APLAR CELLTRION) Award — APLAR 2017

Awards & Recognitions

National & International Awards

All India 1st Rank — DM / MCh Entrance in Medical Oncology, April 2017
First Prize — Update in Management of Breast Cancer National Quiz, AIIMS Delhi, 2017
Best Abstract (APLAR CELLTRION) Award — 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017)
First Prize — 6th SPEAK National Quiz, Nagpur, 2019
First Prize — Hematology Update National Quiz, Delhi, 2019

Professional Memberships

International Association for the Study of Lung Cancer (IASLC)
European Society for Medical Oncology (ESMO)
Indian Cooperative Oncology Network (ICON)

Research & Publications

Published Papers (Selected)

Kancharla H, Jain S, Mishra S, et al. "Fibromyalgia influences health-related quality of life and disease activity in psoriatic arthritis." 2021.
Kumar L, Gundu N, Kancharla H, et al. "Multiple Myeloma: Effect of Induction Therapy on Transplant Outcomes." Clinical Lymphoma, Myeloma and Leukemia. September 2020.
Kancharla H, Gundu N, Pathak N, Khurana S, Pushpam D, Kumar S, Malik PS. "Cytotoxic chemotherapy in advanced non–small cell lung cancer with poor performance status: Retrospective Analysis From Routine Clinical Practice." Current Problems in Cancer. January 2020.
Pramanik R, Kancharla H, Bakhshi S, Sharma A, Gogia A, Mallik P, Sahoo RK, Kumar L. "Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute." Clinical Hematology International. 2019;1(2).
Gundu N, Malik PS, Khurana S, Patty S, Yadav M, Jain D, Kancharla H. "Non-small cell lung carcinoma patients with baseline brain imaging — A prospective observational study." Annals of Oncology. 2019.
Mishra S, Kancharla H, Dogra S, Sharma A. "Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis Patients with Psoriasis (COMPAQ Study)." British Journal of Dermatology. 2017.
Sharma V, Prasada KVR, Kancharla H, Sharma R, Rana SS, Bhasin D. "Pancreatic pleural effusion due to ductal disruption upstream of a tight ductal stricture in patient with chronic calcific pancreatitis." Journal of Digestive Endoscopy. 2015.

Ongoing Research & Clinical Interests

Targeted therapy and immunotherapy in lung and breast cancer
Multiple myeloma and bone marrow transplantation outcomes
Precision oncology and molecular profiling

Estimated Treatment Costs

Procedure / Consultation	Estimated Cost (INR)	Estimated Cost (USD)
Medical Oncology Consultation	₹1,000 – ₹2,500	$12 – $30
Chemotherapy (per cycle, regimen-dependent)	₹20,000 – ₹1,50,000	$240 – $1,800
Targeted Therapy (per month)	₹50,000 – ₹3,00,000	$600 – $3,600
Immunotherapy (per cycle)	₹80,000 – ₹2,50,000	$960 – $3,000
Bone Marrow Transplant (Autologous)	₹10,00,000 – ₹15,00,000	$12,000 – $18,000
Bone Marrow Transplant (Allogeneic)	₹20,00,000 – ₹30,00,000	$24,000 – $36,000
Tumour Marker / Molecular Profiling	₹5,000 – ₹50,000	$60 – $600

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Dr. Harish Kancharla use in Medical Oncologist treatment?

Dr. Harish Kancharla employs the latest evidence-based oncology tools including precision oncology with molecular profiling, targeted therapy (EGFR, ALK, HER2 inhibitors), checkpoint inhibitor immunotherapy (PD-1 / PD-L1), advanced chemotherapy regimens, and bone marrow / stem cell transplantation protocols. Virtual consultations are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.

2. What conditions does Dr. Harish Kancharla specialize in treating?

Dr. Harish Kancharla is a specialist Medical Oncologist in Hyderabad, India, treating lung cancer, breast cancer, gastrointestinal cancers, genitourinary cancers, head and neck cancers, multiple myeloma, leukaemia, and lymphoma. Patients from across India and abroad seek his expertise for advanced and complex cancer cases requiring chemotherapy, targeted therapy, or transplantation.

3. How do I book an appointment with Dr. Harish Kancharla?

Appointments with Dr. Harish Kancharla can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Dr. Harish Kancharla?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Harish Kancharla, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Dr. Harish Kancharla offer second opinions for Medical Oncologist cases?

Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist in Hyderabad, India.

About Dr. Harish Kancharla